The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...

Drug shortage relief targeted as PAI Pharma acquires Nivagen to expand domestic sterile injectable production in Sacramento, Calif.

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

This Direct Meds Consumer Analysis examines oral peptide weight loss formats within the broader context of how shoppers evaluate injectable versus oral GLP-1 administration methods, including the ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

A new generation of appetite-suppressing, injectable drugs have become popular, but recent data suggests "around half of ...

In this week’s Medical Minute, Dr. Lacey Anderson said the first oral GLP-1 medication for weight loss, a pill version of ...